Login Register Cart 0
Generic placeholder image

Current Respiratory Medicine Reviews

Editor-in-Chief

ISSN (Print): 1573-398X
ISSN (Online): 1875-6387

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Meta-Analysis

Noninvasive or Invasive Mechanical Ventilation in Oncohematologic Patients with Acute Respiratory Failure: A Systematic Review and Meta-Analysis

Author(s): Lídia Miranda Barreto*, Cecilia Gómez Ravetti, Nathália Sernizon Guimarães and Vandack Nobre

Volume 18, Issue 1, 2022

Published on: 25 February, 2022

Page: [20 - 28] Pages: 9

DOI: 10.2174/1573398X18666220127104656

Price: $65

conference banner
Abstract

Background: Acute respiratory failure (ARF) in oncohematologic subjects is one of the most common causes of high mortality rates. Noninvasive mechanical ventilation (NIMV) has arisen as an accessory treatment in this clinical scenario.

Objective: This study aimed to compare mortality rates and severity of illness associated with NIMV or invasive mechanical ventilation (IMV) in oncohematologic patients with ARF.

Methods: A search was conducted in the PubMed, SCOPUS, Cochrane Library, LILACS, Web of Science, and gray literature databases, published between November 2007 and May 2021.

Results: Eight studies with a total of 570 patients were included. Patients with good responses to NIMV showed lower values of the Simplified Acute Physiology Score III (SAPS 3) (range: 42±7 to 53±17) when compared to those intubated following NIMV failure (range: 50±11 to 63.3±17.4) and those who underwent IMV as the primary ventilator support (range: 64.9±17.5 to 66±17). Similarly, patients whose NIMV treatment failed and those that initially used IMV had higher baseline values of Sequential Organ Failure Assessment Score (SOFA) when compared to the group with a good response to NIMV. ICU mortality ranged from 40% to 68% in NIMV success, 54% to 79% in NIMV failure, and from 54% to 80% in the group treated with IMV. NIMV therapy had a significant protective effect on mortality (RR=0.71, 95% CI: 0.53-0.94, p=0.02).

Conclusions: NIMV use in oncohematologic patients admitted to the intensive care units (ICU) with ARF was associated with lower mortality. Patients successfully treated in the NIMV group showed lower values of SOFA and SAPS 3 (Prospero Systematic Review -protocol number: 132770).

Keywords: Hematologic diseases, acute respiratory failure, noninvasive ventilation, mechanical ventilation, critical care, patients.

« Previous Next »
Graphical Abstract

[1]
Bird GT, Farquhar-Smith P, Wigmore T, Potter M, Gruber PC. Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: A 5 yr study. Br J Anaesth 2012; 108(3): 452-9.
[http://dx.doi.org/10.1093/bja/aer449] [PMID: 22298243]
[2]
Pène F, Aubron C, Azoulay E, et al. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: A reappraisal of indications for organ failure supports. J Clin Oncol 2006; 24(4): 643-9.
[http://dx.doi.org/10.1200/JCO.2005.03.9073] [PMID: 16380411]
[3]
Azoulay E, Pène F, Darmon M, et al. Managing critically Ill hematology patients: Time to think differently. Blood Rev 2015; 29(6): 359-67.
[http://dx.doi.org/10.1016/j.blre.2015.04.002] [PMID: 25998991]
[4]
Azoulay E, Mokart D, Pène F, et al. Outcomes of critically ill patients with hematologic malignancies: Prospective multicenter data from France and Belgium-a groupe de recherche respiratoire en réanimation onco-hématologique study. J Clin Oncol 2013; 31(22): 2810-8.
[http://dx.doi.org/10.1200/JCO.2012.47.2365] [PMID: 23752112]
[5]
Hilbert G, Gruson D, Vargas F, et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001; 344(7): 481-7.
[http://dx.doi.org/10.1056/NEJM200102153440703] [PMID: 11172189]
[6]
Türkoğlu M, Erdem GU, Suyanı E, et al. Acute respiratory distress syndrome in patients with hematological malignancies. Hematology 2013; 18(3): 123-30.
[http://dx.doi.org/10.1179/1607845412Y.0000000038] [PMID: 23321772]
[7]
Soares M, Salluh JI, Spector N, Rocco JR. Characteristics and outcomes of cancer patients requiring mechanical ventilatory support for >24 hrs. Crit Care Med 2005; 33(3): 520-6.
[http://dx.doi.org/10.1097/01.CCM.0000155783.46747.04] [PMID: 15753742]
[8]
Torres VBL, Soares M. Patients with hematological malignancies admitted to intensive care units: New challenges for the intensivist. Rev Bras Ter Intensiva 2015; 27(3): 193-5.
[http://dx.doi.org/10.5935/0103-507X.20150040] [PMID: 26465241]
[9]
Azoulay E, Pickkers P, Soares M, et al. Acute hypoxemic respiratory failure in immunocompromised patients: The Efraim multinational prospective cohort study. Intensive Care Med 2017; 43(12): 1808-19.
[http://dx.doi.org/10.1007/s00134-017-4947-1] [PMID: 28948369]
[10]
Corrêa TD, Sanches PR, de Morais LC, Scarin FC, Silva E, Barbas CS. Performance of noninvasive ventilation in acute respiratory failure in critically ill patients: A prospective, observational, cohort study. BMC Pulm Med 2015; 15: 144.
[http://dx.doi.org/10.1186/s12890-015-0139-3] [PMID: 26559350]
[11]
Barbas CS, Isola AM, Farias AM, et al. Brazilian recommendations of mechanical ventilation 2013. Part I. Rev Bras Ter Intensiva 2014; 26(2): 89-121.
[http://dx.doi.org/10.5935/0103-507X.20140017] [PMID: 25028944]
[12]
Barbas CS, Ísola AM, Farias AM, et al. Brazilian recommendations of mechanical ventilation 2013. Part 2. Rev Bras Ter Intensiva 2014; 26(3): 215-39.
[http://dx.doi.org/10.5935/0103-507X.20140034] [PMID: 25295817]
[13]
Azoulay E, Lemiale V, Mokart D, et al. Acute respiratory distress syndrome in patients with malignancies. Intensive Care Med 2014; 40(8): 1106-14.
[http://dx.doi.org/10.1007/s00134-014-3354-0] [PMID: 24898895]
[14]
Rathi NK, Haque SA, Nates R, et al. Noninvasivepositive pressure ventilation vs invasive mechanical ventilation as first-line therapy for acute hypoxemic respiratory failure in cancer patients. J Crit Care 2017; 39: 56-61.
[http://dx.doi.org/10.1016/j.jcrc.2017.01.007] [PMID: 28213266]
[15]
Barreto LM, Torga JP, Coelho SV, Nobre V. Main characteristics observed in patients with hematologic diseases admitted to an intensive care unit of a Brazilian university hospital. Rev Bras Ter Intensiva 2015; 27(3): 212-9.
[http://dx.doi.org/10.5935/0103-507X.20150034] [PMID: 26331970]
[16]
Soubani AO, Shehada E, Chen W, Smith D. The outcome of cancer patients with acute respiratory distress syndrome. J Critical Care 2014; 29(1): e7-e12.
[http://dx.doi.org/10.1016/j.jcrc.2013.10.011]
[17]
Adda M, Coquet I, Darmon M, Thiery G, Schlemmer B, Azoulay E. Predictors of noninvasive ventilation failure in patients with hematologic malignancy and acute respiratory failure. Crit Care Med 2008; 36(10): 2766-72.
[http://dx.doi.org/10.1097/CCM.0b013e31818699f6] [PMID: 18766110]
[18]
Azevedo LCP, Caruso P, Silva UVA, et al. Outcomes for patients with cancer admitted to the ICU requiring ventilatory support: Results from a prospective multicenter study. Chest 2014; 146(2): 257-66.
[http://dx.doi.org/10.1378/chest.13-1870] [PMID: 24480886]
[19]
Soares M, Salluh JI, Azoulay E. Noninvasive ventilation in patients with malignancies and hypoxemic acute respiratory failure: a still pending question. J Crit Care 2010; 25(1): 37-8.
[http://dx.doi.org/10.1016/j.jcrc.2009.04.001] [PMID: 19577417]
[20]
Geerse DA, Span LF, Pinto-Sietsma SJ, van Mook WN. Prognosis of patients with haematological malignancies admitted to the intensive care unit: Sequential Organ Failure Assessment (SOFA) trend is a powerful predictor of mortality. Eur J Intern Med 2011; 22(1): 57-61.
[http://dx.doi.org/10.1016/j.ejim.2010.11.003] [PMID: 21238895]
[21]
Metnitz PG, Moreno RP, Almeida E, et al. SAPS 3-From evaluation of the patient to evaluation of the intensive care unit. Part 1: Objectives, methods and cohort description. Intensive Care Med 2005; 31(10): 1336-44.
[http://dx.doi.org/10.1007/s00134-005-2762-6] [PMID: 16132893]
[22]
Moreno RP, Metnitz PG, Almeida E, et al. SAPS 3-From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med 2005; 31(10): 1345-55.
[http://dx.doi.org/10.1007/s00134-005-2763-5] [PMID: 16132892]
[23]
Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327(7414): 557-60.
[http://dx.doi.org/10.1136/bmj.327.7414.557] [PMID: 12958120]
[24]
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315(7109): 629-34.
[http://dx.doi.org/10.1136/bmj.315.7109.629] [PMID: 9310563]
[25]
Depuydt PO, Benoit DD, Roosens CD, Offner FC, Noens LA, Decruyenaere JM. The impact of the initial ventilatory strategy on survival in hematological patients with acute hypoxemic respiratory failure. J Crit Care 2010; 25(1): 30-6.
[http://dx.doi.org/10.1016/j.jcrc.2009.02.016] [PMID: 19682849]
[26]
Gristina GR, Antonelli M, Conti G, et al. Noninvasive versus invasive ventilation for acute respiratory failure in patients with hematologic malignancies: A 5-year multicenter observational survey. Crit Care Med 2011; 39(10): 2232-9.
[http://dx.doi.org/10.1097/CCM.0b013e3182227a27] [PMID: 21666446]
[27]
Squadrone V, Massaia M, Bruno B, et al. Early CPAP prevents evolution of acute lung injury in patients with hematologic malignancy. Intensive Care Med 2010; 36(10): 1666-74.
[http://dx.doi.org/10.1007/s00134-010-1934-1] [PMID: 20533022]
[28]
Molina R, Bernal T, Borges M, et al. Ventilatory support in critically ill hematology patients with respiratory failure. Crit Care 2012; 16(4): R133.
[http://dx.doi.org/10.1186/cc11438] [PMID: 22827955]
[29]
Belenguer-Muncharaz A, Albert-Rodrigo L, Ferrandiz-Sellés A, Cebrián-Graullera G. Ten-year evolution of mechanical ventilation in acute respiratory failure in the hematogical patient admitted to the intensive care unit. Med Intensiva 2013; 37(7): 452-60.
[http://dx.doi.org/10.1016/j.medin.2012.12.011] [PMID: 23890541]
[30]
Barreto LM, Ravetti CG, Athaíde TB, et al. Factors associated with non-invasive mechanical ventilation failure in patients with hematological neoplasia and their association with outcomes. J Intensive Care 2020; 8(68)
[http://dx.doi.org/10.1186/s40560-020-00484-x]
[31]
Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Department of Epidemiology and Community Medicine, University of Ottawa: Canada 2017. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
[32]
Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J 2017; 50(2): 1602426.
[http://dx.doi.org/10.1183/13993003.02426-2016] [PMID: 28860265]
[33]
Peñuelas Ó, Esteban A. Noninvasive ventilation for acute respiratory failure: the next step is to know when to stop. Eur Respir J 2018; 52(2): 1801185.
[http://dx.doi.org/10.1183/13993003.01185-2018] [PMID: 30093558]
[34]
Mehta S, Hill NS. Noninvasive ventilation. Am J Respir Crit Care Med 2001; 163(2): 540-77.
[http://dx.doi.org/10.1164/ajrccm.163.2.9906116] [PMID: 11179136]
[35]
Antonelli M, Conti G, Esquinas A, et al. A multiple-center survey on the use in clinical practice of noninvasive ventilation as a first- line intervention for acute respiratory distress syndrome. Crit Care Med 2007; 35(1): 18-25.
[http://dx.doi.org/10.1097/01.CCM.0000251821.44259.F3] [PMID: 17133177]
[36]
Yeo CD, Kim JW, Kim SC, et al. Prognostic factors in critically ill patients with hematologic malignancies admitted to the intensive care unit. J Crit Care 2012; 27(6): 739.
[http://dx.doi.org/10.1016/j.jcrc.2012.07.014] [PMID: 23217573]
[37]
Ferrer M, Esquinas A, Leon M, Gonzalez G, Alarcon A, Torres A. Noninvasive ventilation in severe hypoxemic respiratory failure: A randomized clinical trial. Am J Respir Crit Care Med 2003; 168(12): 1438-44.
[http://dx.doi.org/10.1164/rccm.200301-072OC] [PMID: 14500259]
[38]
Richards S, Wibrow B, Anstey M, Sidiqi H, Chee A, Ho KM. Determinants of 6-month survival of critically ill patients with an active hematologic malignancy. J Crit Care 2016; 36: 252-8.
[http://dx.doi.org/10.1016/j.jcrc.2016.08.022] [PMID: 27637467]
[39]
Bouteloup M, Perinel S, Bourmaud A, Azoulay E, Mokart D, Darmon M. Outcomes in adult critically ill cancer patients with and without neutropenia: a systematic review and meta-analysis of the Groupe de Recherche en Réanimation Respiratoire du patient d’Onco-Hématologie (GRRR-OH). Oncotarget 2017; 8(1): 1860-70.
[http://dx.doi.org/10.18632/oncotarget.12165] [PMID: 27661125]
[40]
Saillard C, Mokart D, Lemiale V, Azoulay E. Mechanical ventilation in cancer patients. Minerva Anestesiol 2014; 80(6): 712-25. Available from: https://www.minervamedica.it/en/journals/minerva-anestesiologica/article.php?cod=R02Y2014N06A0712
[PMID: 24280820]
[41]
Bündchen DC, Gonzáles AI, Noronha MD, Brüggemann AK, Sties SW, Carvalho TD. Noninvasive ventilation and exercise tolerance in heart failure: A systematic review and meta-analysis. Braz J Phys Ther 2014; 18(5): 385-94.
[http://dx.doi.org/10.1590/bjpt-rbf.2014.0039] [PMID: 25372000]
[42]
Fujiwara Y, Yamaguchi H, Kobayashi K, et al. The therapeutic outcomes of mechanical ventilation in hematological malignancy patients with respiratory failure. Intern Med 2016; 55(12): 1537-45.
[http://dx.doi.org/10.2169/internalmedicine.55.5822] [PMID: 27301502]
[43]
Liu J, Bell C, Campbell V, et al. Noninvasive ventilation in patients with hematologic malignancy. J Intensive Care Med 2017; 885066617690725
[http://dx.doi.org/10.1177/0885066617690725] [PMID: 28142306]
[44]
Amado-Rodríguez L, Bernal T, López-Alonso I, Blázquez-Prieto J, García-Prieto E, Albaiceta GM. Impact of initial ventilatory strategy in hematological patients with acute respiratory failure: A systematic review and meta-analysis. Crit Care Med 2016; 44(7): 1406-13.
[http://dx.doi.org/10.1097/CCM.0000000000001613] [PMID: 26909503]
[45]
Neuschwander A, Lemiale V, Darmon M, et al. Noninvasive ventilation during acute respiratory distress syndrome in patients with cancer: Trends in use and outcome. J Crit Care 2017; 38: 295-9.
[http://dx.doi.org/10.1016/j.jcrc.2016.11.042] [PMID: 28038339]
[46]
Lemiale V, Mokart D, Resche-Rigon M, et al. Effect of noninvasive ventilation vs oxygen therapy on mortality among immunocompromised patients with acute respiratory failure: A randomized clinical trial. JAMA 2015; 314(16): 1711-9.
[http://dx.doi.org/10.1001/jama.2015.12402] [PMID: 26444879]
[47]
Del Sorbo L, Jerath A, Dres M, Parotto M. Non-invasive ventilation in immunocompromised patients with acute hypoxemic respiratory failure. J Thorac Dis 2016; 8(3): E208-16.
[http://dx.doi.org/10.21037/jtd.2016.02.11] [PMID: 27076972]
[48]
Depuydt PO, Benoit DD, Vandewoude KH, Decruyenaere JM, Colardyn FA. Outcome in noninvasively and invasively ventilated hematologic patients with acute respiratory failure. Chest 2004; 126(4): 1299-306.
[http://dx.doi.org/10.1378/chest.126.4.1299] [PMID: 15486396]
[49]
Grasselli G. ICU admission of patients with hematological malignancies: The debate continues. Minerva Anestesiol 2013; 79(2): 113-5. Available from: https://www.minervamedica.it/en/journals/minerva-anestesiologica/article.php?cod=R02Y2013N02A0113
[PMID: 23174924]
[50]
Benoit DD, Depuydt PO. Non-invasive ventilation in patients with hematological malignancies: The saga continues, but where is the finale? Intensive Care Med 2010; 36(10): 1633-5.
[http://dx.doi.org/10.1007/s00134-010-1949-7] [PMID: 20607515]

Rights & Permissions Print Cite
Article Metrics
36
1
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy